Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.40 |
| ▸ | KDM4A | O75164 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.40 |
| ▸ | TET3 | O43151 | 2/20 | 0.40 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6838474 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL5902879 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6838468 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6839516 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6838473 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL16600632 | 0.95 | OR51E2 (0.55) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| Ethylene Glycol SCHEMBL251841 | 0.95 | OR51E2 (0.55) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| Phosphoric Acid SCHEMBL28960961 | 0.93 | OR51E2 (0.52) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL7538335 | 0.80 | OR51E2 (0.63) | OR51E2SMN1; SMN2TET2KDM4AKDM4C | |
| Glycerin SCHEMBL18763119 | 0.80 | OR51E2 (0.82) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | claimed |
| CN-115304897-B | High-strength degradable linear polyester composite material and preparation method thereof | 南通市东方塑胶有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2023-03-09 | — | — | US | claimed |
| US-20230077014-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-03-09 | — | — | US | claimed |
| CN-115304897-A | High-strength degradable linear polyester composite material and preparation method thereof | 南通市东方塑胶有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114752939-A | Etching solution and preparation method and application thereof | 光华科学技术研究院(广东)有限公司 | 2022-07-15 | — | — | CN | claimed |
| WO-2022026960-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC | 2021-11-25 | — | — | US | claimed |
| US-11173246-B2 | Multi-component injection system and methods for tissue repair | ISTO TECHNOLOGIES, INC. (US) | 2021-11-16 | — | — | US | claimed |
| WO-2021158574-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| CN-1326525-C | 10-hydroxy camptothecin long cyclic liposome and its freeze aried preparation | UNIV FUDAN (CN) | 2007-07-18 | — | — | CN | claimed |
| CN-1907270-A | Method for preparing protein-polysaccharide vitreum slow release microsphere by using low-temperature aqueous-aqueous phase emulsion | UNIV SHANGHAI JIAOTONG (CN) | 2007-02-07 | — | — | CN | claimed |
| CN-1297253-C | Medicinal transferring system for intracephalic transference of medicine | UNIV FUDAN (CN) | 2007-01-31 | — | — | CN | claimed |
| CN-1903939-A | Polysaccharide polymer having protein large molecule and its preparation method | UNIV SHANGHAI JIAOTONG (CN) | 2007-01-31 | — | — | CN | claimed |
| CN-1887274-A | Prepn process of slow released microsphere of protein-polysaccharide vitreous particle | UNIV SHANGHAI JIAOTONG (CN) | 2007-01-03 | — | — | CN | claimed |
| CN-1679575-A | 10-hydroxy camptothecine long circulating vesica and its freeze-dried preparation | UNIV FUDAN (CN) | 2005-10-12 | — | — | CN | claimed |
| CN-1650864-A | 10-hydroxy camptothecin long cyclic liposome and its freeze aried preparation | UNIV FUDAN (CN) | 2005-08-10 | — | — | CN | claimed |
| CN-1208390-C | Epoxy crosslinking agent and its prepn and application in preparing biodegradable material | UNIV JINAN (CN) | 2005-06-29 | — | — | CN | claimed |
| CN-1582902-A | Medicinal transferring system for intracephalic transference of medicine | UNIV FUDAN (CN) | 2005-02-23 | — | — | CN | claimed |
| EP-0463470-A2 | Process for the preparation of a fluorotetrahydrofuranone derivative | F. HOFFMANN-LA ROCHE AG (CH) | 1992-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR1, CNR2, OPRD1 | OR51E2 1657/4885SMN1; SMN2 2427/4885LMNA 1677/4885 |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | CNR2, CNR1, FAAH | OR51E2 3823/4885SMN1; SMN2 2461/4885LMNA 1759/4885 |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR2, CNR1, FAAH | OR51E2 2530/4885SMN1; SMN2 3905/4885LMNA 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.